- ￥2890
- LSM Bio
- 0.31-20ng/ml
- 0.1ng/ml
- 进口
- SELI-66056h
- 2025年09月10日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 灵敏度：
0.1ng/ml
- 库存：
50
- 供应商：
LSM Bio
- 检测范围：
0.31-20ng/ml
- 检测方法：
夹心法/竞争法
- 应用：
夹心法/竞争法EL体外定量检测人血清、血浆或其它相关生物液体中soluble Urokinase- type Plasminogen Activator Receptor蛋白浓度
- 适应物种：
人
- 标记物：
soluble Urokinase- type Plasminogen Activator Receptor
- 样本：
血清、血浆或其它相关生物液体中天然和重组蛋白
- 规格：
96T
Human suPAR ELISA kit
Catalog SELI-66056h
Packing 48Tests/96Tests
ELISA Method Sandwich ELISA Species Human
Sample Human serum, plasma, tissue homogenates and other biological fluids and Recombinant suPAR
Detect Range 0.31-20ng/ml sensitivity
ELISA Intend Use
Human suPAR ELISA kit is a Sandwich ELISA KIT detecting the concentration of suPAR in Human serum, plasma, tissue homogenates and other biological fluids.
(ELISA KIT is only for Research Only, not for the diagnostic Use!)
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Article: Quercetin and lithium chloride potentiate the protective effects of carvedilol against renal ischemia-reperfusion injury in high-fructose, high-fat diet-fed swiss albino mice independent of renal lipid signaling
Author：Asmaa M.RezkabIslam A.A.E.-H.IbrahimaMona F.MahmoudaAmr A.A.Mahmouda1
Received 6 September 2020, Revised 12 October 2020, Accepted 28 October 2020, Available online 4 November 2020.
Chemico-Biological Interactions
Available online 4 November 2020, 109307
doi: doi.org/10.1016/j.cbi.2020.109307
RFLP Molecular Analysis of the Urokinase-Type Plasminogen Activator Gene
attachments. One such enzyme, the serine protease urokinase-type plasminogen activator (uPA), converts enzymatically inactive plasminogen into the widely acting protease plasmin, which degrades several extracellular matrix components and also activates
as the Northern blot (2 ). Both are, then, often key elements in establishing the identity of nucleic acids of interest. Northern blot analysis was used by us as a tool in order to answer the question whether or not the nuclear transcripitional apparatus of human
The determination of the protein content of urokinase-type plasminogen activator (uPA) and its inhibitor, PAI-1, in breast cancer tissue extracts is used clinically to identify patients at risk to experience disease recurrence (metastasis
技术资料
